Subject
Current Medicinal Chemistry is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Atta-ur-Rahman, FRS (Kings College University of Cambridge Cambridge, UK). The journal covers developments in medicinal chemistry and rational drug design and publishes original research reports and review papers. A related journal titled Current Medicinal Chemistry – Anti-Cancer Agents ISSN 1568-0118 was launched in 2001, and retitled as Anti-Cancer Agents in Medicinal Chemistry from the start of 2006 with ISSN 1871-5206 (print), ISSN 1875-5992 (online). Source: Wikipedia (en)
Editions published in Current Medicinal Chemistry 6225
-
Towards protein surface mimetics
-
Combinatorial chemistry techniques applied to nonpeptide integrin antagonists
-
Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants
-
Podophyllotoxins: current status and recent developments
-
NMR spectroscopy as a tool to investigate the structural basis of anticancer drugs
-
Chemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines
-
Dopamine D4 receptors: a new opportunity for research on schizophrenia
-
Structural aspects of monoamine oxidase and its reversible inhibition
-
Novel biological response modifiers derived from thalidomide
-
Antiproliferative naphthopyrans: biological activity, mechanistic studies and therapeutic potential
-
Biosynthetic anthracyclines
-
Investigations of structural requirements for endothelin antagonism
-
Novel benztropine [3a-(diphenylmethoxy)tropane] analogs as probes for the dopamine transporter
-
Thrombin inhibitor design
-
The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applications
-
Utilization of natural products for treatment of blood diseases.
-
Octanol-water partition: searching for predictive models
-
1. The chemistry and pharmacology of indole-3-carbinol (indole-3-methanol) and 3-(methoxymethyl)indole. [Part II].
-
Use of commercially available hemoglobin standards to quantitatively calibrate a high performance liquid chromatography method
-
New trends in antimicrobial development
-
Nonpolyglutamatable antifolates as inhibitors of thymidylate synthase (TS) and potential antitumour agents
-
1 - 1. The chemistry and pharmacology of indole-3-carbinol (indole-3-methanol) and 3-(methoxymethyl)indole. [Part I]
-
Beta-lactamase inhibitors: agents to overcome bacterial resistance
-
Progress towards the discovery of orally active thrombin inhibitors
-
Bioisosteric approach in the design of new dopaminergic/serotonergic ligands
-
The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors.
-
Multi-component methodologies in solid-phase organic synthesis
-
Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?
-
Recent advances in neurokinin receptor antagonists
-
Glutathione S-transferases--a review.
-
Microbial models of mammalian metabolism of xenobiotics: An updated review
-
PT523 and other aminopterin analogs with a hemiphthaloyl-L-ornithine side chain: exceptionally tight-binding inhibitors of dihydrofolate reductase which are transported by the reduced folate carrier but cannot form polyglutamates
Subject -